Literature DB >> 23837080

Primary non-alcoholic fatty liver disease in hypertensive patients.

Luminita Latea1, Stefania Negrea, Sorana Bolboaca.   

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is considered the most common liver disease affecting 15-25% of the general population. AIMS: The aim of this study was to investigate the prevalence of NAFLD and the relationship between insulin sensitivity and NAFLD in grade III high and very high cardiovascular additional risk essential hypertensive patients according to the circadian blood pressure (BP) rhythm.
METHOD: This four-year prospective study was conducted at the Department of Internal Medicine at Cluj-Napoca's Diagnosis and Treatment Centre in Romania. The study included grade III essential hypertensive patients. Hypertensive patients were divided into four groups according to the diurnal index (DI) from ABPM monitoring: dipper (D), non-dipper (ND), reverse-dipper (RD), and extreme-dipper (ED). All hypertensive patients underwent 24 ABPM, blood tests and abdominal ultrasonography for the diagnosis of fatty liver disease.
RESULTS: Thirty-five hypertensive patients were included in the study, with 31.42% ND, 11.43% RD, 8.57% ED and 48.57% D. The prevalence of NAFLD was significantly higher in ND, RD and ED when compared to D. When compared to the dipper group of hypertensive patients a statistically significantly higher level of plasma insulin was observed: in non-dipper [86.3±17.9pmol/l vs. 62.2±203pmol/l, p<0.05], in reverse dipper [88.3±18.6pmol/l vs. 62.2±20.3pmol/l] and in extreme-dippers [86.7±16.88pmol/l vs. 62.2±20.3 pmol/l, p<0.05].
CONCLUSION: The altered dipping status (ND, RD, ED) of hypertension associated with a higher insulin resistance could be the pathogenetic link between the NAFLD and altered blood pressure status. Altered BP status could be a marker of NAFLD in hypertensive patients.

Entities:  

Keywords:  Essential hypertension; NAFLD; circadian blood pressure rhythm; insulin resistance; primary non-alcoholic fatty liver disease

Year:  2013        PMID: 23837080      PMCID: PMC3702137          DOI: 10.4066/AMJ.2013.1648

Source DB:  PubMed          Journal:  Australas Med J        ISSN: 1836-1935


  30 in total

1.  Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives.

Authors:  K Kario; T G Pickering; T Matsuo; S Hoshide; J E Schwartz; K Shimada
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

2.  Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study.

Authors:  Roberto Sega; Rita Facchetti; Michele Bombelli; Giancarlo Cesana; Giovanni Corrao; Guido Grassi; Giuseppe Mancia
Journal:  Circulation       Date:  2005-04-04       Impact factor: 29.690

Review 3.  Night-time blood pressure patterns and target organ damage: a review.

Authors:  Faye S Routledge; Judith A McFetridge-Durdle; C R Dean
Journal:  Can J Cardiol       Date:  2007-02       Impact factor: 5.223

Review 4.  Nonalcoholic fatty liver disease.

Authors:  Leon A Adams; Keith D Lindor
Journal:  Ann Epidemiol       Date:  2007-08-28       Impact factor: 3.797

5.  Body fat distribution, liver enzymes, and risk of hypertension: evidence from the Western New York Study.

Authors:  Saverio Stranges; Maurizio Trevisan; Joan M Dorn; Jacek Dmochowski; Richard P Donahue
Journal:  Hypertension       Date:  2005-10-03       Impact factor: 10.190

Review 6.  Insulin resistance in hypertension and cardiovascular disease.

Authors:  Valéria Lamounier-Zepter; Monika Ehrhart-Bornstein; Stefan R Bornstein
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2006-09       Impact factor: 4.690

Review 7.  Non-alcoholic fatty liver disease: a brief review.

Authors:  B van Hoek
Journal:  Scand J Gastroenterol Suppl       Date:  2004

8.  Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure.

Authors:  Cesare Cuspidi; Stefano Meani; Maurizio Salerno; Cristiana Valerio; Veronica Fusi; Barbara Severgnini; Laura Lonati; Fabio Magrini; Alberto Zanchetti
Journal:  J Hypertens       Date:  2004-02       Impact factor: 4.844

Review 9.  Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome.

Authors:  Chin Hee Kim; Zobair M Younossi
Journal:  Cleve Clin J Med       Date:  2008-10       Impact factor: 2.321

Review 10.  Nondipping blood pressure patterns among individuals with essential hypertension: a review of the literature.

Authors:  Faye Routledge; Judith McFetridge-Durdle
Journal:  Eur J Cardiovasc Nurs       Date:  2006-07-13       Impact factor: 3.908

View more
  6 in total

1.  Transcriptional networks implicated in human nonalcoholic fatty liver disease.

Authors:  Hua Ye; Wei Liu
Journal:  Mol Genet Genomics       Date:  2015-04-08       Impact factor: 3.291

2.  Association between nocturnal blood pressure dipping and insulin resistance in children affected by NAFLD.

Authors:  Ugo Giordano; Claudia Della Corte; Giulia Cafiero; Daniela Liccardo; Attilio Turchetta; Kazem Mohammad Hoshemand; Danilo Fintini; Giorgio Bedogni; Maria Chiara Matteucci; Valerio Nobili
Journal:  Eur J Pediatr       Date:  2014-06-17       Impact factor: 3.183

3.  Increased levels of systolic blood pressure within the normal range are associated with significantly elevated risks of nonalcoholic fatty liver disease.

Authors:  Sheng-Jie Wu; Hai Zou; Gui-Qi Zhu; Li-Ren Wang; Qi Zhang; Ke-Qing Shi; Ji-Bo Han; Wei-Jian Huang; Martin Braddock; Yong-Ping Chen; Ming-Hua Zheng
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

4.  Elevated Alanine Aminotransferase in Early Pregnancy and Subsequent Development of Gestational Diabetes and Preeclampsia.

Authors:  Seung Mi Lee; Joong Shin Park; You Jung Han; Won Kim; Seung Hyun Bang; Byoung Jae Kim; Chan Wook Park; Moon Young Kim
Journal:  J Korean Med Sci       Date:  2020-07-06       Impact factor: 2.153

Review 5.  Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications.

Authors:  Claudio Tana; Stefano Ballestri; Fabrizio Ricci; Angelo Di Vincenzo; Andrea Ticinesi; Sabina Gallina; Maria Adele Giamberardino; Francesco Cipollone; Richard Sutton; Roberto Vettor; Artur Fedorowski; Tiziana Meschi
Journal:  Int J Environ Res Public Health       Date:  2019-08-26       Impact factor: 3.390

6.  Assessment of the relationship between non-alcoholic fatty liver disease and diabetic complications.

Authors:  Li-Hui Yan; Biao Mu; Yue Guan; Xinyu Liu; Nan Zhao; Da Pan; Shao-Zhen Wang
Journal:  J Diabetes Investig       Date:  2016-04-20       Impact factor: 4.232

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.